Article Versions Notes

Hoshi K, Kanno M, Goto A, Ugawa Y, Furukawa K, Arai H, Miyajima M, Takahashi K, Hattori K, Kan K, et al. Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases. International Journal of Molecular Sciences. 2023; 24(7):6084. https://doi.org/10.3390/ijms24076084

Hoshi, Kyoka, Mayumi Kanno, Aya Goto, Yoshikazu Ugawa, Katsutoshi Furukawa, Hiroyuki Arai, Masakazu Miyajima, Koichi Takahashi, Kotaro Hattori, Keiichi Kan, and et al. 2023. "Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases" International Journal of Molecular Sciences 24, no. 7: 6084. https://doi.org/10.3390/ijms24076084

Hoshi, K., Kanno, M., Goto, A., Ugawa, Y., Furukawa, K., Arai, H., Miyajima, M., Takahashi, K., Hattori, K., Kan, K., Saito, T., Yamaguchi, Y., Mitsufuji, T., Araki, N., & Hashimoto, Y. (2023). Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases. International Journal of Molecular Sciences, 24(7), 6084. https://doi.org/10.3390/ijms24076084